Api Impurities

Pioneers in the industry, we offer 200mg pirfeekam pretomanid tablet from India.

200mg Pirfeekam Pretomanid Tablet

Request Callback

₹ 99 / Strip Get Latest Price

Pretomanid Tablet Nitroimidazole Core of BPaL Regimen for XDR-TB Narix Pharmaceuticals Narix Pharmaceuticals supplies Pretomanid Tablets, a bicyclic nitroimidazole with dual mechanism � inhibits mycolic acid synthesis aerobically and generates reactive nitrogen species anaerobically � making it active against both replicating and non-replicating M. tuberculosis. Core of the WHO-recommended BPaL (Bedaquiline + Pretomanid + Linezolid) regimen. Key Therapeutic Uses: � XDR-TB and treatment-intolerant MDR-TB � BPaL regimen � 6-month BPaL regimen � 90% cure rate in trials � Highly drug-resistant TB cases � TB with multiple prior treatment failures Available Strengths: 200 mg Product Highlights: � Core BPaL regimen component � 90% cure in XDR-TB � Dual mechanism � aerobic + anaerobic TB activity � WHO-GMP, DCGI approved � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #PretomanidTablet #BPaLRegimen #XDRTBMedicine #MDRTBTablet #NitroimidazoleTB #PretomanidManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine
X

Contact Us

Naman (CEO)
Narix Pharmaceuticals Private Limited
Floor No. 1, Godown No.13, 12/14, Mohata Market, Musafirkhana RD, Crawford Market
Mumbai - 400001, Maharashtra, India

Get Directions
Send Email
Share: